Clinical Trials
2 trialsNCT05433116 2025-12-02
Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC
Universität des Saarlandes
Phase 2 Active not recruiting
NCT03524326 2025-05-13
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed